Toxicity of emerging contaminants (pharmaceuticals and nanomaterials) as single compounds and in mixtures in model and native aquatic organisms
Roles of natural organic matter (NOM) and co-contaminants in modulating toxicity of carbon nanomaterials and pharmaceuticals
Biomarkers indicating exposure and effects of emerging contaminants
Linkages between land use and contaminant accumulation and effects in freshwater bivalves and native and artificial oyster beds
• Enantioselective toxicity of chiral chemicals